This episode dives deep into the science and future potential of retatrutide, a groundbreaking triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. You’ll learn how it works, what clinical trials are showing about dramatic weight loss and metabolic improvements, and what side effects and safety considerations are important to know. We also explore its role in obesity management, type 2 diabetes, fatty liver disease, and cardiovascular health, as well as the challenges of access and cost. Perfect for anyone curious about the next frontier in peptide therapies and how they may transform long-term health.